PUBLIC CONTRACT · 2024
Aquisição de BEVACizumab (Zirabev) 100mg/4ml sol inj fr IV e BEVACizumab (Zirabev) 400mg/16ml sol inj IV, TRASTUzumab (Trazimera) 150 mg po sol inj fr IV, TRASTUzumab (Trazimera) 420 mg po sol inj fr IV, Etanercept 50mg/1ml Sol inj Can SC, Etanercept 50mg/1ml Sol inj Ser SC, Etanercept 25 mg/0.5 ml Sol inj Can SC
- Contract value
- €229,214.50
- Signed on
- 25 January 2024
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10884789PUBLISHED DESCRIPTION
Aquisição de BEVACizumab (Zirabev) 100mg/4ml sol inj fr IV e BEVACizumab (Zirabev) 400mg/16ml sol inj IV, TRASTUzumab (Trazimera) 150 mg po sol inj fr IV, TRASTUzumab (Trazimera) 420 mg po sol inj fr
Parties involved
- Place of performance
- Portugal, Braga, Braga
- NUTS region
- PT112 - Cávado
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- LAB. PFIZER, LDA. · Tax ID 500162166
Values and timeline
- Contract price
- €229,214.50
- Procedure base price
- €229,214.50
- Total effective price
- Not reported on Portal BASE
- Publication date
- 23 August 2024
- Award date
- 18 January 2024
- Signing date
- 25 January 2024
- Performance period
- 120 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7188093
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.